1. Home
  2. RENB vs GEG Comparison

RENB vs GEG Comparison

Compare RENB & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RENB
  • GEG
  • Stock Information
  • Founded
  • RENB 2011
  • GEG 1994
  • Country
  • RENB United States
  • GEG United States
  • Employees
  • RENB N/A
  • GEG N/A
  • Industry
  • RENB Biotechnology: Pharmaceutical Preparations
  • GEG Computer Software: Prepackaged Software
  • Sector
  • RENB Health Care
  • GEG Technology
  • Exchange
  • RENB Nasdaq
  • GEG Nasdaq
  • Market Cap
  • RENB 56.2M
  • GEG 54.7M
  • IPO Year
  • RENB N/A
  • GEG N/A
  • Fundamental
  • Price
  • RENB $0.29
  • GEG $2.16
  • Analyst Decision
  • RENB
  • GEG
  • Analyst Count
  • RENB 0
  • GEG 0
  • Target Price
  • RENB N/A
  • GEG N/A
  • AVG Volume (30 Days)
  • RENB 1.6M
  • GEG 19.7K
  • Earning Date
  • RENB 05-15-2025
  • GEG 05-07-2025
  • Dividend Yield
  • RENB N/A
  • GEG N/A
  • EPS Growth
  • RENB N/A
  • GEG N/A
  • EPS
  • RENB N/A
  • GEG N/A
  • Revenue
  • RENB N/A
  • GEG $19,626,000.00
  • Revenue This Year
  • RENB N/A
  • GEG N/A
  • Revenue Next Year
  • RENB N/A
  • GEG N/A
  • P/E Ratio
  • RENB N/A
  • GEG N/A
  • Revenue Growth
  • RENB N/A
  • GEG 64.34
  • 52 Week Low
  • RENB $0.28
  • GEG $1.70
  • 52 Week High
  • RENB $2.34
  • GEG $2.20
  • Technical
  • Relative Strength Index (RSI)
  • RENB 37.08
  • GEG 69.14
  • Support Level
  • RENB $0.30
  • GEG $1.98
  • Resistance Level
  • RENB $0.33
  • GEG $2.14
  • Average True Range (ATR)
  • RENB 0.05
  • GEG 0.10
  • MACD
  • RENB 0.01
  • GEG 0.01
  • Stochastic Oscillator
  • RENB 5.07
  • GEG 86.70

About RENB Renovaro Biosciences Inc.

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

About GEG Great Elm Group Inc.

Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.

Share on Social Networks: